FDA Inspection 1194475 — Department of Defense - Navy

Department of Defense - Navy — FEI 1476899

The FDA completed an inspection of Department of Defense - Navy on December 9, 2022 in North Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 9, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Chicago, IL (United States)